{"count": 4, "results": [{"_id": "17541377", "pmid": 17541377, "title": "Sitagliptin/metformin (Janumet) for type 2 diabetes.", "journal": "Med Lett Drugs Ther", "date": "2007-06-04T00:00:00Z", "meta_date_publication": "2007 Jun 4", "meta_volume": "49", "meta_issue": "1262", "meta_pages": "45-7", "score": 50088.11, "text_hl": "@CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@Sitagliptin@@@/@CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Sitagliptin_Phosphate_Metformin_Hydrochloride_Drug_Combination</m> @CHEMICAL_MESH:D000068899 @@@Janumet@@@) for @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Sitagliptin/metformin (Janumet) for type 2 diabetes. Med Lett Drugs Ther. 2007 Jun 4;49(1262):45-7. PMID: 17541377", "BibTeX": "@article{17541377, title={Sitagliptin/metformin (Janumet) for type 2 diabetes.}, journal={Med Lett Drugs Ther}, volume={49}, number={1262}, pages={45-7}}"}}, {"_id": "21189532", "pmid": 21189532, "title": "[Medication of the month. Sitagliptin-metformin fixed combination (Janumet)].", "journal": "Rev Med Liege", "authors": ["Scheen AJ"], "date": "2010-11-01T00:00:00Z", "meta_date_publication": "2010 Nov", "meta_volume": "65", "meta_issue": "11", "meta_pages": "648-54", "score": 50081.344, "text_hl": "@<m>CHEMICAL_Sitagliptin_Phosphate_Metformin_Hydrochloride_Drug_Combination</m> @CHEMICAL_MESH:D000068899 @@@Janumet@@@ (50/850 mg or 50/1.000 mg), twice daily, is indicated in the treatment of @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and is currently reimbursed in Belgium after failure of @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy or the prior demonstration of the efficacy of adding sitaglitptin (Januvia) to @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Scheen AJ. [Medication of the month. Sitagliptin-metformin fixed combination (Janumet)]. Rev Med Liege. 2010 Nov;65(11):648-54. PMID: 21189532", "BibTeX": "@article{21189532, title={[Medication of the month. Sitagliptin-metformin fixed combination (Janumet)].}, author={Scheen AJ}, journal={Rev Med Liege}, volume={65}, number={11}, pages={648-54}}"}}, {"_id": "23319848", "pmid": 23319848, "title": "Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus.", "journal": "P T", "authors": ["St Onge EL", "Miller S", "Clements E"], "date": "2012-12-01T00:00:00Z", "meta_date_publication": "2012 Dec", "meta_volume": "37", "meta_issue": "12", "meta_pages": "699-708", "score": 50078.89, "text_hl": "@CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@Sitagliptin@@@/@CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@<m>CHEMICAL_Sitagliptin_Phosphate_Metformin_Hydrochloride_Drug_Combination</m> @CHEMICAL_MESH:D000068899 @@@janumet@@@) as combination therapy in the treatment of @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type-2 diabetes mellitus@@@.", "citations": {"NLM": "St Onge EL, Miller S, Clements E. Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus. P T. 2012 Dec;37(12):699-708. PMID: 23319848", "BibTeX": "@article{23319848, title={Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus.}, author={St Onge EL and Miller S and Clements E}, journal={P T}, volume={37}, number={12}, pages={699-708}}"}}, {"_id": "30743780", "pmid": 30743780, "title": "Initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin for patients with Type 2 diabetes mellitus.", "journal": "Expert Rev Endocrinol Metab", "authors": ["Vilsbøll T"], "date": "2008-01-01T00:00:00Z", "doi": "10.1586/17446651.3.1.13", "meta_date_publication": "2008 Jan", "meta_volume": "3", "meta_issue": "1", "meta_pages": "13-19", "score": 50072.43, "text_hl": "Recently, the US FDA approved initial combination therapy with @CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@sitagliptin@@@ and @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Sitagliptin_Phosphate_Metformin_Hydrochloride_Drug_Combination</m> @CHEMICAL_MESH:D000068899 @@@Janumet@@@ ) in order to help more @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 diabetes mellitus@@@ get closer to accepted glycemic control targets, as recommended by standard guidelines. ", "citations": {"NLM": "Vilsbøll T. Initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin for patients with Type 2 diabetes mellitus. Expert Rev Endocrinol Metab. 2008 Jan;3(1):13-19. PMID: 30743780", "BibTeX": "@article{30743780, title={Initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin for patients with Type 2 diabetes mellitus.}, author={Vilsbøll T}, journal={Expert Rev Endocrinol Metab}, volume={3}, number={1}, pages={13-19}}"}}]}